Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson's disease
about
Beyond boundaries--Eph:ephrin signaling in neurogenesis.Trans-Activation between EphA and FGFR Regulates Self-Renewal and Differentiation of Mouse Embryonic Neural Stem/Progenitor Cells via Differential Activation of FRS2αRegulation of endogenous neural stem/progenitor cells for neural repair-factors that promote neurogenesis and gliogenesis in the normal and damaged brainEphA4 may contribute to microvessel remodeling in the hippocampal CA1 and CA3 areas in a mouse model of temporal lobe epilepsy.Therapeutic targeting of EPH receptors and their ligands.Harnessing neurogenesis for the possible treatment of Parkinson's disease.Eph receptors and ephrins: therapeutic opportunities.The Neural Stem Cell Microenvironment: Focusing on Axon Guidance Molecules and Myelin-Associated Factors.Neurogenesis in the Hippocampus of Patients with Temporal Lobe Epilepsy.Regional expression and ultrastructural localization of EphA7 in the hippocampus and cerebellum of adult rat.Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment.The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE.Ephrin-A3 reverse signaling regulates hippocampal neuronal damage and astrocytic glutamate transport after transient global ischemia.Roles of Eph/ephrin bidirectional signaling in central nervous system injury and recovery.Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal modelRoles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous system
P2860
Q27687317-727B9A8B-2E7B-4284-B73D-65CD9EB4CF27Q35646243-CCBECFF1-9CEE-434F-B5E1-1FD3CDA9A44DQ36542970-0F6F6A95-D618-4B03-8798-F8A60EC89496Q37707520-1D8A0038-B50E-4D26-A230-120AB66C440AQ38174793-30502611-B786-4185-B350-F3C23B068DA8Q38203839-B73228C0-9EB2-4534-A63A-E5AF258ED6AEQ38257853-043BC709-C587-425E-A1DB-803272725918Q38372245-A582C37F-580C-43F9-A97F-07102F0D0ED3Q38697204-10EC0899-4113-4A03-BBFB-A360CB6429DCQ46318061-3BBE7AEA-5837-45B4-ACB1-58433431D028Q46514042-5B424F20-CBF9-46F8-9AB3-E663331CB762Q48414222-916F056F-73E1-4D49-898D-07CE11EE6645Q48650566-67099401-EAC3-45D0-A90E-C6A704B77F77Q49884500-CB4EB3A1-EFEE-45DF-A63C-9DC3A18C4235Q58786372-263B814E-F8AC-4B2F-9E7C-4B35184FBE79Q58805400-2EBC4F4D-9021-4428-8B3E-C5CE9AED569F
P2860
Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson's disease
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@ast
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@en
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@nl
type
label
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@ast
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@en
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@nl
prefLabel
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@ast
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@en
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@nl
P2093
P2860
P1433
P1476
Ephrin-A1-mediated dopaminergi ...... t model of Parkinson's disease
@en
P2093
Hideto Miwa
Ichiro Nakanishi
Kazushige Sakaguchi
Masayasu Miyajima
Takahiro Sawada
Tomoyoshi Kondo
Xuefeng Jing
P2860
P304
P356
10.1371/JOURNAL.PONE.0032019
P407
P577
2012-01-01T00:00:00Z